These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33487592)

  • 1. Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma.
    Song S; Chen Q; Li Y; Lei G; Scott A; Huo L; Li CY; Estrella JS; Correa A; Pizzi MP; Ma L; Jin J; Liu B; Wang Y; Xiao L; Hofstetter WL; Lee JH; Weston B; Bhutani M; Shanbhag N; Johnson RL; Gan B; Wei S; Ajani JA
    Gut; 2021 Dec; 70(12):2238-2248. PubMed ID: 33487592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pan-Bcl2 Inhibitor AT101 Activates the Intrinsic Apoptotic Pathway and Causes DNA Damage in Acute Myeloid Leukemia Stem-Like Cells.
    Zhang L; Zhou Y; Chen K; Shi P; Li Y; Deng M; Jiang Z; Wang X; Li P; Xu B
    Target Oncol; 2017 Oct; 12(5):677-687. PubMed ID: 28710745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Mcl-1 with the pan-Bcl-2 family inhibitor (-)BI97D6 overcomes ABT-737 resistance in acute myeloid leukemia.
    Pan R; Ruvolo VR; Wei J; Konopleva M; Reed JC; Pellecchia M; Andreeff M; Ruvolo PP
    Blood; 2015 Jul; 126(3):363-72. PubMed ID: 26045609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AT101 exerts a synergetic efficacy in gastric cancer patients with 5-FU based treatment through promoting apoptosis and autophagy.
    Wei X; Duan W; Li Y; Zhang S; Xin X; Sun L; Gao M; Li Q; Wang D
    Oncotarget; 2016 Jun; 7(23):34430-41. PubMed ID: 27144437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proapoptotic protein Smac mediates apoptosis in cisplatin-resistant ovarian cancer cells when treated with the anti-tumor agent AT101.
    Hu W; Wang F; Tang J; Liu X; Yuan Z; Nie C; Wei Y
    J Biol Chem; 2012 Jan; 287(1):68-80. PubMed ID: 22052903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sabutoclax, pan-active BCL-2 protein family antagonist, overcomes drug resistance and eliminates cancer stem cells in breast cancer.
    Hu Y; Yagüe E; Zhao J; Wang L; Bai J; Yang Q; Pan T; Zhao H; Liu J; Zhang J
    Cancer Lett; 2018 Jun; 423():47-59. PubMed ID: 29496539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AT-101, a pan-Bcl-2 inhibitor, leads to radiosensitization of non-small cell lung cancer.
    Moretti L; Li B; Kim KW; Chen H; Lu B
    J Thorac Oncol; 2010 May; 5(5):680-7. PubMed ID: 20354451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting anti-apoptotic Bcl-2 by AT-101 to increase radiation efficacy: data from in vitro and clinical pharmacokinetic studies in head and neck cancer.
    Zerp SF; Stoter TR; Hoebers FJ; van den Brekel MW; Dubbelman R; Kuipers GK; Lafleur MV; Slotman BJ; Verheij M
    Radiat Oncol; 2015 Jul; 10():158. PubMed ID: 26223311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo evaluation of AT-101 (R-(-)-gossypol acetic acid) in androgen-independent growth of VCaP prostate cancer cells in combination with surgical castration.
    Loberg RD; McGregor N; Ying C; Sargent E; Pienta KJ
    Neoplasia; 2007 Dec; 9(12):1030-7. PubMed ID: 18084610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of apoptosis and antitumor effects of a small molecule inhibitor of Bcl-2 and Bcl-xl, gossypol acetate, in multiple myeloma in vitro and in vivo.
    Lin J; Wu Y; Yang D; Zhao Y
    Oncol Rep; 2013 Aug; 30(2):731-8. PubMed ID: 23708869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Bcl-2 family members with the BH3 mimetic AT-101 markedly enhances the therapeutic effects of chemotherapeutic agents in in vitro and in vivo models of B-cell lymphoma.
    Paoluzzi L; Gonen M; Gardner JR; Mastrella J; Yang D; Holmlund J; Sorensen M; Leopold L; Manova K; Marcucci G; Heaney ML; O'Connor OA
    Blood; 2008 Jun; 111(11):5350-8. PubMed ID: 18292288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa.
    Meng Y; Tang W; Dai Y; Wu X; Liu M; Ji Q; Ji M; Pienta K; Lawrence T; Xu L
    Mol Cancer Ther; 2008 Jul; 7(7):2192-202. PubMed ID: 18645028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AT101-Loaded Cubosomes as an Alternative for Improved Glioblastoma Therapy.
    Flak DK; Adamski V; Nowaczyk G; Szutkowski K; Synowitz M; Jurga S; Held-Feindt J
    Int J Nanomedicine; 2020; 15():7415-7431. PubMed ID: 33116479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ApoG2 as the most potent gossypol derivatives inhibits cell growth and induces apoptosis on gastric cancer cells.
    Xin J; Zhan YH; Xia LM; Zhu HW; Nie YZ; Liang JM; Tian J
    Biomed Pharmacother; 2013 Feb; 67(1):88-95. PubMed ID: 23201009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABT-263 induces apoptosis and synergizes with chemotherapy by targeting stemness pathways in esophageal cancer.
    Chen Q; Song S; Wei S; Liu B; Honjo S; Scott A; Jin J; Ma L; Zhu H; Skinner HD; Johnson RL; Ajani JA
    Oncotarget; 2015 Sep; 6(28):25883-96. PubMed ID: 26317542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic antitumoral activity and induction of apoptosis by novel pan Bcl-2 proteins inhibitor apogossypolone with adriamycin in human hepatocellular carcinoma.
    Mi JX; Wang GF; Wang HB; Sun XQ; Ni XY; Zhang XW; Tang JM; Yang DJ
    Acta Pharmacol Sin; 2008 Dec; 29(12):1467-77. PubMed ID: 19026166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AT-101 enhances gefitinib sensitivity in non-small cell lung cancer with EGFR T790M mutations.
    Zhao R; Zhou S; Xia B; Zhang CY; Hai P; Zhe H; Wang YY
    BMC Cancer; 2016 Jul; 16():491. PubMed ID: 27431492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AT-101, a small molecule inhibitor of anti-apoptotic Bcl-2 family members, activates the SAPK/JNK pathway and enhances radiation-induced apoptosis.
    Zerp SF; Stoter R; Kuipers G; Yang D; Lippman ME; van Blitterswijk WJ; Bartelink H; Rooswinkel R; Lafleur V; Verheij M
    Radiat Oncol; 2009 Oct; 4():47. PubMed ID: 19852810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells.
    Kaza N; Kohli L; Graham CD; Klocke BJ; Carroll SL; Roth KA
    PLoS One; 2014; 9(5):e96733. PubMed ID: 24824755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoid sensitisation in Mixed Lineage Leukaemia-rearranged acute lymphoblastic leukaemia by the pan-BCL-2 family inhibitors gossypol and AT-101.
    Spijkers-Hagelstein JA; Schneider P; Pinhanços SM; Garrido Castro P; Pieters R; Stam RW
    Eur J Cancer; 2014 Jun; 50(9):1665-74. PubMed ID: 24703900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.